Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC

NCT04136535 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV

Interventions

DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Anlotinib

Sponsor

Fudan University